Literature DB >> 18461611

The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China.

Xueshan Xia1, Ling Lu, Kok Keng Tee, Wenhua Zhao, Jianguo Wu, Jing Yu, Xiaojie Li, Yixiong Lin, Muhammad Mahmood Mukhtar, Curt H Hagedorn, Yutaka Takebe.   

Abstract

The Yunnan province is the epicenter of HIV-1 epidemics in China and a center for drug trafficking to the other parts of the world. In six prefectures of this province, a total of 132 IDUs were recruited to determine the sero-prevalence of HCV and HIV-1 and the positive rates were 93.94% and 68.18%, respectively (P<0.001). Co-infection with HCV and HIV-1 was found among 89 IDUs, of whom several HCV fragments were amplified and sequenced. Sequences of the HCV 5'NCR-C and NS5B region were determined from 82 IDUs. Phylogenetic analyses showed consistent genotyping among 80 IDUs. Among them HCV genotypes 1a, 1b, 3a, 3b, 6a, 6n, and a tentatively assigned novel 6u subtype were found in 1 (1.25%), 16 (20%), 19 (23.75%), 24 (30%), 4 (5%), 9 (11.25%) and 7 (8.75%) individuals, respectively. In two IDUs, genotyping results were discordant, suggesting mixed HCV infections or recombination. The proportion of patients with HCV 1b tended to decrease from the north to south and from the east to west in this province. Genotype 3 and 6 strains were more frequent in the southern prefectures. The novel subtype 6u strains were only detected in Dehong which borders Myanmar. Our findings showed a unique pattern of HCV genotype distribution, which is similar to that in the southeastern Asian countries but distinct from that among the general population in China. Routes of drug trafficking and the resulting high prevalence of HIV-1 infection may have contributed to this pattern of HCV genotype distribution.

Entities:  

Mesh:

Year:  2008        PMID: 18461611      PMCID: PMC2999914          DOI: 10.1002/jmv.21204

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  44 in total

1.  Hepatitis C--global prevalence (update).

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2000-01-21

2.  Adoption of injection practices in heroin users in Guangxi Province, China.

Authors:  S Lai; J Chen; D Celentano; J B Page; H Lai; J Yang; W Liu; C B McCoy; X F Yu
Journal:  J Psychoactive Drugs       Date:  2000 Jul-Sep

3.  Prevalence of hepatitis C virus infection among clients of HIV counseling and testing sites--Connecticut, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-07-13       Impact factor: 17.586

4.  Rapid spread of hepatitis C virus among injecting-drug users in the Philippines: Implications for HIV epidemics.

Authors:  Dorothy M Agdamag; Seiji Kageyama; Evelyn T Alesna; Rontgene M Solante; Prisca S Leaño; Anna Marie L Heredia; Ilya P Abellanosa-Tac-An; Eutiquio T Vibal; Lourdes D Jereza; Hiroshi Ichimura
Journal:  J Med Virol       Date:  2005-10       Impact factor: 2.327

5.  Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.

Authors:  Linqi Zhang; Zhiwei Chen; Yunzhen Cao; Jian Yu; Guanghan Li; Wenjie Yu; Ning Yin; Shan Mei; Li Li; Peter Balfe; Tian He; Lei Ba; Fengwen Zhang; His-Hsun Lin; Man-Fung Yuen; Ching-Lung Lai; David D Ho
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 6.  Hepatitis C virus genotyping: clinical implications and methods.

Authors:  F S Nolte
Journal:  Mol Diagn       Date:  2001-12

7.  Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.

Authors:  Syria Laperche; Karine Saune; Paul Dény; Gilles Duverlie; Sophie Alain; Marie-Laure Chaix; Catherine Gaudy; Françoise Lunel; Jean-Michel Pawlotsky; Christopher Payan; Bruno Pozzetto; Catherine Tamalet; Vincent Thibault; Sophie Vallet; Françoise Bouchardeau; Jacques Izopet; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

9.  Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b.

Authors:  Zhenyu Chen; Karen E Weck
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Hepatitis C virus infection, Linxian, China.

Authors:  Mingdong Zhang; Xiu-Di Sun; Steven D Mark; Wen Chen; Lara Wong; Sanford M Dawsey; You-Lin Qiao; Joseph F Fraumeni; Philip R Taylor; Thomas R O'Brien
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more
  40 in total

1.  A panel of 16 full-length HCV genomes was characterized in China belonging to genotypes 1-6 including subtype 2f and two novel genotype 6 variants.

Authors:  Ru Xu; Wangxia Tong; Lin Gu; Chunhua Li; Yongshui Fu; Ling Lu
Journal:  Infect Genet Evol       Date:  2013-09-05       Impact factor: 3.342

2.  Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities.

Authors:  Ling Lu; Min Wang; Wenjie Xia; Linwei Tian; Ru Xu; Chunhua Li; Jingxing Wang; Xia Rong; Huaping Xiong; Ke Huang; Jieting Huang; Tatsunori Nakano; Phil Bennett; Yong Zhang; Linqi Zhang; Yongshui Fu
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

3.  Proapoptotic IL-18 in patients with chronic hepatitis C treated with pegylated interferon-alpha.

Authors:  He YingLi; Lin Shumei; Yang Qian; Chen Tianyan; Zhao Yingren; Chen Wei
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

4.  High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China.

Authors:  Hong Shang; Ping Zhong; Jing Liu; Xiaoxu Han; Di Dai; Min Zhang; Ke Zhao; Rongzhen Xu; Xiao-Fang Yu
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

5.  Hepatitis C virus genotypes in Myanmar.

Authors:  Nan Nwe Win; Tatsuo Kanda; Shingo Nakamoto; Osamu Yokosuka; Hiroshi Shirasawa
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

6.  Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant.

Authors:  Ling Lu; Chunhua Li; Jie Yuan; Teng Lu; Hiroaki Okamoto; Donald G Murphy
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

Review 7.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China.

Authors:  Di Tian; Lin Li; Yongjian Liu; Hanping Li; Xiaoyuan Xu; Jingyun Li
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  Eight novel hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6.

Authors:  Hongren Wang; Zhiguo Yuan; Eleanor Barnes; Manqiong Yuan; Chunhua Li; Yongshui Fu; Xueshan Xia; Gang Li; Paul N Newton; Manivanh Vongsouvath; Paul Klenerman; Oliver G Pybus; Donald Murphy; Kenji Abe; Ling Lu
Journal:  J Gen Virol       Date:  2012-09-26       Impact factor: 3.891

10.  The current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequences.

Authors:  Ling Lu; Wangxia Tong; Lin Gu; Chunhua Li; Teng Lu; Kok Keng Tee; Guihua Chen
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.